跳至主要内容
临床试验/CTRI/2020/02/023496
CTRI/2020/02/023496尚未招募未知

To evaluate the in-vivo safety and efficacy of skin care formulation in terms of non comedogenic effect, skin lightening effect and even skin tone in healthy male and female subjects. - Not Applicable

Adroit Biomed Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Healthy Indian / Asian males and female subjects
  • 2) 36 subjects aged between 18 and 60 years old will be selected for the study
  • a)Having oily to mixed oily skin on the face
  • b)Having wheatish to dark complexion &
  • c)Having atleast one well defined superficial hyper-pigmentory spot ( >3.5mm in diameter)
  • 3) Volunteer willing to participate in the study and provide signed informed consent for the same

排除标准

  • 1) Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
  • 2) Having refused to give her assent by signing the consent form
  • 3) Taking part in another study liable to interfere with this study
  • 4) Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
  • 5) Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
  • 6) Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • 7) Being epileptic
  • 8) Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • 9) Having cutaneous hypersensitivity
  • 10) Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
  • 11) Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
  • 12) Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
  • 13) Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
  • 14) Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).
  • 15) Having started, changed or stopped a hormonal treatment (hormonal contraception, Hormone Replacement Therapy) in the past 3 months.
  • 16) Having started, changed or stoppedher tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months
  • 17) Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoïn, amiodarone, metals, minocyclineâ?¦) in the previous 6 months
  • 18) Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-caroteneâ?¦)
  • 19) Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask â?¦) or having applied self-tanning products in the week preceding the start of the study
  • 20) Having applied products with anti-wrinkle action (Retinoic acid, retinol, retinaldehyde, isotretinoin, A.H.A...) in the 2 weeks preceding the start of the study
  • 21) Having applied products with a depigmenting action (hydroquinone or derivatesâ?¦) in the 4 weeks preceding the start of the study.
  • 22) Having undergone physical and/or chemical treatments of the spots (liquid nitrogen, dry ice, pulsed flash lamp, dermabrasion, chemical peel â?¦) in the previous 6 months

研究者

发起方
Adroit Biomed Ltd

相似试验

Evaluation of the Safety and efficacy of skin care... | 临床试验